Hasil Filter

5

Total database: 17430
Struktur (SMILES)
5 (100.0%)
Target
4 (80.0%)
Genomik
0 (0%)
Referensi
5 (100.0%)

Tipe Molekul

Distribusi Wujud Zat

Status Regulasi

Hasil Pencarian (5)

Imipenem Approved DB01598
small molecule | CAS: 64221-86-9

Imipenem is a semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains.[label] It is stable to many beta-lactamases. Similar comp…

Kategori:
Agents that reduce seizure thresholdAmidesAnti-Bacterial Agents +12
Target Protein:
Penicillin-binding protein 2Penicillin-binding protein 1BPenicillin-binding protein 1A +3
Waktu ParuhWhen given via IV i…
Vol. DistribusiThe reported volume…
KlirensThe total clearance…
Genetik -
Meropenem Approved DB00760
small molecule | CAS: 96036-03-2

Meropenem is a broad-spectrum carbapenem antibiotic. It is active against Gram-positive and Gram-negative bacteria. Meropenem exerts its action by penetrating bacterial cells readily and interfering with the synthesis of vital cell wall components, which lead…

Kategori:
AmidesAnti-Bacterial AgentsAnti-Infective Agents +10
Target Protein:
D-alanyl-D-alanine carboxypeptidase DacB
Waktu ParuhApproximately 1 hou…
Vol. Distribusi-
Klirens-
Genetik -
Nacubactam DB15353
small molecule | CAS: 1452458-86-4

Nacubactam is under investigation in clinical trial NCT03174795 (A Study to Investigate the Pharmacokinetics of RO7079901 and Meropenem in Participants With a Complicated Urinary Tract Infection).

Kategori:
AmidesAza Compounds
Target Protein:
Beta-lactamase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Pralurbactam DB19437
small molecule | CAS: 2163782-59-8

Pralurbactam is under investigation in clinical trial NCT06633718 (Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAI).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vaborbactam Approved DB12107
small molecule | CAS: 1360457-46-0

Vaborbactam is a ?-lactamase inhibitor based on a cyclic boronic acid pharmacophore.[A32053] It has been used in trials investigating the treatment of bacterial infections in subjects with varying degrees of renal insufficiency. In August 2017, a combination …

Kategori:
AcidsAcids, NoncarboxylicAnti-Infective Agents +6
Target Protein:
Beta-lactamaseBeta-lactamaseCarbapenem-hydrolyzing beta-lactamase KPC +7
Waktu ParuhThe half life of va…
Vol. DistribusiThe steady-state vo…
KlirensThe mean renal clea…
Genetik -